phase 3_completion
saveSanofi — meningococcal [serotypes A, C, W-135, Y] vaccine (MenQuadfi) (Phase III Trial Completion)
community read0 votes
Therapy area: Infectious Disease. Indication: Neisseria meningitidis Infections
Data sources
globaldata
Found something off?
same company · ±60 days · 3
related news · 8
- statSTAT+: FDA leadership shakeup widens following Makary’s departure
- statSTAT+: Colombia wins a key court ruling over a compulsory license issued for an HIV medicine
- statSTAT+: Pharmalittle: We’re reading about Medicare and Alzheimer’s drugs, estrogen patch shortages, and more
- onclivePost–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Cancer
- statTrump reportedly plans to fire FDA Commissioner Makary
- statSTAT+: Capricor Therapeutics accuses Nippon Shinyaku of slow-walking plans on Duchenne drug
- statSTAT+: Up and down the ladder: The latest comings and goings
- statSTAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and more
comments(0)
5-min edit window · permanent after that